bpbp
Member
Καλησπέρα.
Θα ήθελα τη βοήθειά σας.
Κάποια παραδείγματα:
"A noninferiority claim could be made if the two-sided alpha-adjusted CI upper bound for the hazard ratio for overall survival, durvalumab versus sorafenib, was less than 1.08."
"A two-sided, alpha level adjusted confidence interval (CI) will be constructed around the estimate."
"Therefore, results of the primary and secondary endpoints presented in this review are based on two-sided alpha-adjusted 98.02% confidence intervals (CIs). "
Θα ήθελα τη βοήθειά σας.
Κάποια παραδείγματα:
"A noninferiority claim could be made if the two-sided alpha-adjusted CI upper bound for the hazard ratio for overall survival, durvalumab versus sorafenib, was less than 1.08."
"A two-sided, alpha level adjusted confidence interval (CI) will be constructed around the estimate."
"Therefore, results of the primary and secondary endpoints presented in this review are based on two-sided alpha-adjusted 98.02% confidence intervals (CIs). "